What is LifePoint Inc?
develops, manufactures, and sells IMPACT Test System, a diagnostic testing and screening device.
LFPI · Verdict
Moderate reward · high risk
LFPI has limited near-term tailwinds — cash flow and volatility weigh on the model output.
Based on 88% data coverage
LFPI · Verdict
Weak vs peers
Weak vs peers
-158% return on equity
Earnings +28.6% CAGR
Model-based scoring. For information only — not financial advice.
develops, manufactures, and sells IMPACT Test System, a diagnostic testing and screening device. It serves workplaces, ambulances, pharmacies, law enforcements, and home health care markets. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 9.70K.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.